中国经济网北京10月17日讯 据北交所网站消息，北京证券交易所上市委员会定于2025年10月24日召开2025年第26次上市审核 委员会审议会议，审议的发行人为江苏爱舍伦医疗科技集团股份有限公司（以下简称"爱舍伦"）。 招股书显示，爱舍伦本次拟募集资金30,000.00万元，用于凯普乐公共卫生医疗物资产业园建设项目。 | 序号 | 项目名称 | 投资总额 | 募集资金 使用金额 | 项目备案证号 | 环评批复备案号 | | --- | --- | --- | --- | --- | --- | | | 凯普乐公共卫生医疗 | 67,046.45 | 30.000.00 | 2020-341861- | 宣环评 | | | 物资产业园建设项目 | | | 27-03-037766 | [2023]30 号 | | | 合计 | 67,046.45 | 30,000.00 | | | 截至招股说明书签署日，江苏诺维克科技投资有限公司持股比例为79.58%，为公司控股股东，报告期内，公司的控股股东未 发生变更。张勇直接持有公司1.97%的股权，通过控股股东江苏诺维克间接持有公司79.58%的股权，通过洛威尼森及普洛 ...

"这些，这些，还有这些，全都来自中国！"站在位于Embakasi港口附近的巨大医疗仓库中，肯尼亚医疗用品管理局（KEMSA） 战略伙伴关系与资源调动负责人John Kabuchi对21世纪经济报道记者说，"中国制造"占到了肯尼亚医疗物资的90%以上，为该国 的医疗保障提供了强力支持。 仓库里，一排排金属骨架整齐排列，一个个巨大的纸箱整齐地摆放在货架上。21世纪经济报道记者看到了一个个熟悉的中文名 字：万孚生物、山东安得、艾博生物、天康医疗、上海达华……从检测试剂到防护设备，从避孕产品到长效杀虫蚊帐，各种"中 国制造"产品堆满了仓库。 KEMSA是肯尼亚卫生部下属的国有企业，依据2013年《KEMSA法案》设立，取代了自1901年以来以不同名称存在的医疗物资 管理机构。其主要职责是为公共卫生设施和项目提供专业的医疗物流服务，包括采购、仓储和分发药品及医疗物资，以支持国 家健康战略计划和全民健康覆盖（UHC）目标。 Kabuchi表示，KEMSA致力于提供高质量、价格合理的健康产品和技术（Health Products and Technologies，HPTs），以支持肯 尼亚及东非地区的医疗服务，改善和拯救生 ...

Summary of Key Points from Conference Call Industry or Company Involved - The discussion primarily revolves around the trade negotiations between the United States and China, focusing on tariffs, supply chains, and technology controls. Core Points and Arguments 1. **Tariff Adjustments** - The U.S. proposed to reduce the average tariff on Chinese goods from 145% to 50%-60%, with some essential consumer goods (such as electronics and textiles) potentially lowered to 25% - China responded by committing to adjust its 125% retaliatory tariffs but insisted that the U.S. must first correct its unilateral tariff errors, emphasizing that adjustments should be based on the "principle of reciprocity" - The timeline for implementation suggests that the first round of tariff reductions may take effect after May 12, prioritizing consumer electronics and medical supplies [1][1][1] 2. **Supply Chain and Key Product Exemptions** - Both parties discussed providing temporary exemptions for critical products such as medical supplies and rare earth materials to alleviate short-term supply pressures [1][1][1] 3. **Rare Earth Export Restrictions** - The U.S. requested China to ease restrictions on rare earth exports; however, China did not relent and instead intensified efforts to combat rare earth smuggling as a countermeasure [2][2][2] 4. **Technology Controls and Industrial Policy** - The stalemate continues in high-tech sectors like semiconductors and AI, with the U.S. maintaining technology export restrictions while China demands the lifting of sanctions and recognition of the legitimacy of the "Made in China 2025" strategy - No fundamental compromises were reached, but both sides agreed to establish a technical exchange working group to facilitate further negotiations [2][2][2] 5. **Dialogue Mechanism Establishment** - Both parties consented to create a regularized economic and trade consultation mechanism, designating lead representatives and scheduling regular meetings, with plans to release a joint statement detailing these arrangements on May 12 [2][2][2] Other Important but Potentially Overlooked Content - The emphasis on the principle of reciprocity in tariff adjustments indicates a strategic approach by China to ensure balanced negotiations - The establishment of a technical exchange working group may signal a willingness to engage in more collaborative discussions despite existing tensions in technology sectors - The focus on critical product exemptions highlights the urgency of addressing supply chain vulnerabilities amid ongoing trade disputes [1][2][2]